Geode Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $6.84K | Hold |
|
|||||
|
2023
Q4 | $11.5K | Hold |
|
|||||
|
2023
Q3 | $13.5K | Buy |
|
|||||
|
2023
Q2 | $21.6K | Sell |
|
|||||
|
2023
Q1 | $43.3K | Hold |
|
|||||
|
2022
Q4 | $44K | Sell |
|
|||||
|
2022
Q3 | $92K | Hold |
|
|||||
|
2022
Q2 | $246K | Sell |
|
|||||
|
2022
Q1 | $458K | Hold |
|
|||||
|
2021
Q4 | $685K | Buy |
|
|||||
|
2021
Q3 | $865K | Buy |
|
|||||
|
2021
Q2 | $1.12M | Sell |
|
|||||
|
2021
Q1 | $2.33M | Buy |
|
|||||
|
2020
Q4 | $1.77M | Buy |
|
|||||
|
2020
Q3 | $1.81M | Buy |
|
|||||
|
2020
Q2 | $1.34M | Buy |
|
|||||
|
2020
Q1 | $115K | Hold |
|
|||||
|
2019
Q4 | $116K | Buy |
|
|||||
|
2019
Q3 | $79K | Hold |
|
|||||
|
2019
Q2 | $54K | Buy |
|
|||||
|
2019
Q1 | $30K | Hold |
|
|||||
|
2018
Q4 | $23K | Hold |
|
|||||
|
2018
Q3 | $49K | Hold |
|
|||||
|
2018
Q2 | $52K | Hold |
|
|||||
|
2018
Q1 | $58K | Buy |
|
|||||
|
2017
Q4 | $257K | Sell |
|
|||||
|
2017
Q3 | $108K | Hold |
|
|||||
|
2017
Q2 | $96K | Sell |
|
|||||
|
2017
Q1 | $127K | Buy |
|
|||||
|
2016
Q4 | $229K | Buy |
|
|||||
|
2016
Q3 | $432K | Hold |
|
|||||
|
2016
Q2 | $418K | Hold |
|
|||||
|
2016
Q1 | $490 | Buy |
|
|||||
|
2015
Q4 | $903K | Sell |
|
|||||
|
2015
Q3 | $410K | Buy |
|
|||||
|
2015
Q2 | $284K | Sell |
|
|||||
|
2015
Q1 | $329K | Buy |
|
|||||
|
2014
Q4 | $939K | Buy |
|
|||||
|
2014
Q3 | $803K | Hold |
|
|||||
|
2014
Q2 | $1.05M | Buy |
|
|||||
|
2014
Q1 | $1.12M | Buy |
|
|||||
|
2013
Q4 | $214K | Buy |
|
|||||
|
2013
Q3 | $151K | Buy |
|